Summary
SYK Chart
SYK Stock Likely to Rise Following FDA Clearance for OptaBlate System
Stryker secures FDA clearance for OptaBlate BVN, a groundbreaking nerve ablation system designed to treat chronic vertebrogenic lower back pain with precision and safety.
Stryker receives FDA clearance for OptaBlate® BVN Basivertebral Nerve Ablation System
Stryker's first basivertebral nerve ablation system targets the basivertebral nerve to provide relief from chronic* vertebrogenic low back pain. PORTAGE, Mich.
Stryker Corporation (SYK) Bank of America Securities 2025 Global Healthcare Conference (Transcript)
Stryker Corporation (NYSE:SYK ) Bank of America Securities 2025 Global Healthcare Conference May 13, 2025 4:40 PM ET Company Participants Preston Wells - Chief Financial Officer Jason Beach - Vice President, Finance and Investor Relations Conference Call Participants Travis Steed - Bank of America Travis Steed [abrupt start] the Bank of America medical device analyst and continuing our day of Medtech conversations. Next up we've got Stryker Corporation, Preston Wells, newly appointed CFO; and Jason Beach, VP of Finance and IR.
Stryker Corporation Dividends
 SYK 2 months ago | Other | €0.74 Per Share |
| SYK 5 months ago | Other | €0.74 Per Share |
| SYK 8 months ago | Other | €0.7 Per Share |
| SYK 11 months ago | Other | €0.7 Per Share |
| SYK 27 Mar 2024 | Other | €0.7 Per Share |
Stryker Corporation Earnings
| 28 Jul 2025 (54 Days) Date | | - Cons. EPS | - EPS |
| 28 Apr 2025 Date | | - Cons. EPS | - EPS |
| 28 Jan 2025 Date | | - Cons. EPS | - EPS |
| 31 Oct 2024 Date | | - Cons. EPS | - EPS |
| 29 Oct 2024 Date | | - Cons. EPS | - EPS |
| SYK 2 months ago | Other | €0.74 Per Share |
| SYK 5 months ago | Other | €0.74 Per Share |
| SYK 8 months ago | Other | €0.7 Per Share |
| SYK 11 months ago | Other | €0.7 Per Share |
| SYK 27 Mar 2024 | Other | €0.7 Per Share |
| 28 Jul 2025 (54 Days) Date | | - Cons. EPS | - EPS |
| 28 Apr 2025 Date | | - Cons. EPS | - EPS |
| 28 Jan 2025 Date | | - Cons. EPS | - EPS |
| 31 Oct 2024 Date | | - Cons. EPS | - EPS |
| 29 Oct 2024 Date | | - Cons. EPS | - EPS |
Stryker Corporation (SYK) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
What is the earnings per share?
When is the next earnings date?
Has Stryker Corporation ever had a stock split?
Stryker Corporation Profile
| Medical - Devices Industry | Healthcare Sector | Mr. Kevin A. Lobo CEO | XBER Exchange | US8636671013 ISIN |
| US Country | 53,000 Employees | - Last Dividend | 17 May 2004 Last Split | - IPO Date |
Overview
Stryker Corporation is a leading medical technology company with a primary focus on providing innovative solutions in the medical field. The company operates through two main segments: MedSurg and Neurotechnology, and Orthopaedics and Spine. These segments cater to a wide array of medical needs, from total joint replacements and trauma surgeries to advanced neurosurgical and neurovascular solutions. Founded in 1941 and based in Portage, Michigan, Stryker has grown into a global entity, distributing its products in approximately 75 countries. The company's commitment to enhancing patient and caregiver outcomes is evident through its extensive product portfolio, advanced medical devices, and a strategic approach to market distribution and customer engagement.
Products and Services
Stryker Corporation offers a diverse range of products and services designed to cater to various facets of medical care, spanning various specialties and requirements. These include:
- Orthopaedics and Spine: This involves providing implants used in total joint replacements for hip, knee, and shoulder surgeries, along with trauma and extremities surgeries. The segment is also known for its spinal implant products, which consist of systems for cervical and thoracolumbar applications, including fixation, minimally invasive, and interbody systems targeted at spinal injury, complex spine, and degenerative therapies.
- MedSurg and Neurotechnology: A broad range of surgical equipment and surgical navigation systems fall under this segment, alongside endoscopic and communications systems. Stryker also offers products aimed at enhancing patient handling, emergency medical care, and intensive care through disposable products, reprocessed and remanufactured medical devices. Additionally, clinical communication and workflow solutions, along with a variety of medical device products for different specialties, are provided, focusing on patient and caregiver safety technologies.
- Neurosurgical, Neurovascular, and Craniomaxillofacial Implant Products: This category includes products for minimally invasive endovascular procedures, brain and open skull-based surgical procedures, and biosurgery products like synthetic bone grafts and vertebral augmentation products. For the treatment of acute ischemic and hemorrhagic stroke, minimally invasive products are offered. The segment also covers craniomaxillofacial implant products, including devices for cranial, maxillofacial, and chest wall surgeries, as well as dural substitutes and sealants.
These products are made available to doctors, hospitals, and other healthcare facilities through a blend of company-owned subsidiaries and branches, supplemented by a network of third-party dealers and distributors worldwide.
Contact Information
